Havana.- Cuba’s health system this year began administering a new Cuban-made vaccine against the Haemofilus Influenza.
The synthetic vaccine, the only one of its kind in the world, also protects children against sepsis and rheumatoid arthritis.
Clinical trials proved that the vaccine is safe, has a great immune effect, can generate the antibodies that children need to be protected against the disease, and its efficacy rate is above 99 percent.
The vaccine was developed by the Center for Research on Synthetic Antigens, attached to the University of Havana.
The company Heber Biotec is in charge of producing and commercializing the vaccine.